Use of tamoxifen by young women is influenced by fertility concerns
2015-08-24
(Press-News.org) The risk of breast cancer recurrence and mortality is decreased by endocrine therapy (ET) such as tamoxifen, but younger patients may decline it or discontinue treatment early if they are concerned about fertility, according to a study published August 24 in the JNCI: Journal of the National Cancer Institute.
To explore the reasons for lower initiation and continuation with tamoxifen treatment by younger women with breast cancer, Jacqueline S. Jeruss M.D., Ph.D. of The University of Michigan School of Medicine, Ann Arbor, MI and colleagues conducted a study of 515 premenopausal patients, younger than age 45, with stage 0-III hormone receptor-positive breast cancer for whom tamoxifen was recommended. Demographic, disease, and treatment data, as well as patient concerns, were obtained from chart review. Patients who did not initiate or discontinued tamoxifen treatment were also interviewed by telephone.
Women who received a diagnosis of ductal carcinoma in situ, declined radiation therapy, did not receive chemotherapy, had a history of smoking, or had fertility concerns were less likely to initiate or more likely to discontinue tamoxifen treatment early. The primary reasons that patients gave for not initiating, delaying, or discontinuing treatment were concerns about side effects and the ability to become pregnant.
The researchers write "Despite the importance of fertility to young breast cancer patients, availability of fertility preservation options, and relative safety of pregnancy among breast cancer survivors, fertility preservation is often underutilized and under-discussed in clinical settings."
In an accompanying editorial, Shoshana M. Rosenberg, Sc.D., M.P.H., and Ann H. Partridge, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, MA, write that these results "...not only shed new light on the role of side effects and concern about side effect on non-adherence in young women, but also draw attention to the impact of fertility concerns on adjuvant ET decision-making." They comment that although the retrospective nature of the study limits its generalizability, "Further understanding of patterns of non-adherence and non-persistence in young women...may ultimately lead to more targeted and timely interventions to improve adherence to therapy."
INFORMATION:
Contact info:
Article: Jacqueline S. Jeruss, M.D., Ph.D.; jjeruss@med.umich.edu
Editorial: Ann H. Partridge, M.D., M.P.H., ann_partridge@dfci.harvard.edu
ELSE PRESS RELEASES FROM THIS DATE:
2015-08-24
DALLAS, Aug. 24, 2015 -- Deaths from heart disease have declined dramatically over the last few decades but young people, particularly women, are not sharing equally in that improvement, according to new research in the American Heart Association's journal Circulation.
Using data on adults age 25 and older, researchers tracked annual percentage changes in heart disease death rates between three time periods: 1979-1989, 1990-1999 and 2000-2011. Death rates in adults 65 and over declined consistently over the decades, with accelerating improvements since 2000.
In contrast, ...
2015-08-24
ANN ARBOR, Mich. -- Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.
In addition, the study found fertility concerns led a quarter of women who started tamoxifen to stop taking it before the recommended treatment period ended.
"Our study points toward the importance of fertility to young breast cancer patients. We need to find a way to bridge the gap between this patient survivorship goal and our concerns as physicians to facilitate the best treatment ...
2015-08-24
HOUSTON - (Aug. 24, 2015) - Electronic triggers designed to search for key data, developed by researchers at Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
The full study can be found in the Journal of Clinical Oncology.
"Our computerized triggers scanned huge amounts of patient data in the electronic health record and flagged individuals at risk for delays in follow-up of cancer-related abnormal clinical findings," ...
2015-08-24
Danny has become a degenerate, that is, the tropical depression weakened. Satellite and Hurricane Hunter aircraft data showed that Danny degenerated into an elongated area of low pressure near the Windward Islands during the afternoon (local time) on August 24. Meanwhile two other developing low pressure areas lie to the east of Danny.
Satellite data from NOAA's GOES-East satellite at 14:45 UTC (10:45 a.m. EDT) on August 24, showed Danny had become stretched out into a trough of low pressure. At 11 a.m. EDT (1500 UTC), the remnants of Danny were located near latitude ...
2015-08-24
TALLAHASSEE, Fla. -- In the second part of his lab's recent one-two punch, Florida State University researcher Daniel Kaplan said he has solved a cell division mystery in a way that will intrigue the makers of cancer-fighting drugs.
The key, said Kaplan, a College of Medicine Department of Biomedical Sciences researcher, is a protein called Treslin.
"It can target cancer cells," he said. "Most chemotherapy also targets rapidly dividing normal cells, but this seems to have promise for not doing that. Drug companies are going to be excited."
Before cells can divide, ...
2015-08-24
SAN DIEGO, Calif. -- (Aug. 24, 2015) -- A new survey on sexual victimization issues at the University of Oregon reaffirms previous findings that there is a need to increase awareness about available services, while decreasing negative perceptions of institutional support.
Psychology professor Jennifer Freyd provided preliminary findings of the UO survey at the 20th International Summit & Training on Violence, Abuse & Trauma during a keynote session on "Campus Sexual Assault: Current Research and Prevention Approaches."
New issues also surfaced among the key findings ...
2015-08-24
CAMBRIDGE, Mass. (August 24, 2015) - By teasing apart the structure of an enzyme vital to the infectious behavior of the parasites that cause toxoplasmosis and malaria, Whitehead Institute scientists have identified a potentially 'drugable' target that could prevent parasites from entering and exiting host cells.
Although toxoplasmosis causes disease only in certain individuals-including immunocompromised patients, pregnant women, and their infants, the T. gondii parasite is closely related to Plasmodium, which causes malaria. Research on T. gondii can provide insights ...
2015-08-24
Commonly used antidepressant drugs change levels of a key signaling protein in the brain region that processes both pain and mood, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published August 24 in the Proceedings of the National Academy of Sciences (PNAS). The newly understood mechanism could yield insights into more precise future treatments for nerve pain and depression.
The study was conducted in mice suffering from chronic neuropathic pain, a condition which is caused in mice and humans by nerve damage. Chronic neuropathic ...
2015-08-24
Bacteria are best known as free-living single cells, but in reality their lives are much more complex. To survive in harsh environments, many species of bacteria will band together and form a biofilm--a collection of cells held together by a tough web of fibers that offers protection from all manner of threats, including antibiotics. A familiar biofilm is the dental plaque that forms on teeth between brushings, but biofilms can form almost anywhere given the right conditions.
Biofilms are a huge problem in the health care industry. When disease-causing bacteria establish ...
2015-08-24
Atlanta, GA - August 24, 2015 - Respiratory syncytial virus (RSV), which is the leading cause of childhood respiratory hospitalizations among premature babies, can be detected from the clothes worn by caregivers/visitors who are visiting infants in the neonatal intensive care unit (NICU), according to research being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.
"The aim of this study was to identify potential sources of transmission of RSV in the NICU to better inform infection control strategies," said Dr. Nusrat ...
LAST 30 PRESS RELEASES:
[Press-News.org] Use of tamoxifen by young women is influenced by fertility concerns
